Genentech and Human Longevity Inc. announce multi-year agreement

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

GENENTECH and Human Longevity Inc. signed a multi-year agreement to conduct whole genome sequencing of tens of thousands of de-identified samples provided by Genentech, a member of the Roche Group.

HLI will sequence genomes to 30x coverage and analyze the data. Financial details of the agreement were not disclosed.

HLI is building a comprehensive integrated human genotype and phenotype database, the HLI Knowledgebase, using Illumina’s HiSeq X Ten and HiSeq 2500 sequencing machines and Pac Bio RS II instruments.

YOU MAY BE INTERESTED IN

Login